Haemophilus Vaccine Development
Epiglottitis incidence reduced after Haemophilus influenzae vaccine
Published in Vaccine Weekly, October 5th, 2005
According to recent research from Australia, "Acute epiglottitis due to infection with Haemophilus influenzae type b (Hib) is much less common in children following the introduction of Hib vaccination; however, adult epiglottitis cases have not decreased. In addition, epiglottitis hospitalizations are consistently more numerous than notifications and the reason for this is not clear. To more accurately describe the clinical, etiological, and epidemiological features of epiglottitis and to ascertain the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2005-10-05)
More Articles from Vaccine Weekly
- Avian Influenza
Methods to contain pandemic influenza at the source examined - Melanoma Vaccine Development
Protection against melanoma found without autoimmune depigmentation - Tuberculosis Vaccine Development
Variant tricarboxylic acid cycle found in M. tuberculosis - Vaccine Adjuvant
Role of adjuvants in development of mucosal vaccines reviewed - Vaccine Efficacy
QPCR used to assign infectious potencies to adenovirus-based vaccines - Addiction Medicine
Drug users in Ireland remain vulnerable to bloodborne pathogens - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
